Latest News

SGLT2 inhibitors, GLP-1 RAs are effective, but costly in T2D

Publish date: July 10, 2019
By
Randy Dotinga
Katie Lennon

 

Recommended Reading

CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma
MDedge Internal Medicine
New findings cast more doubt on ‘fat-but-fit’ theory
MDedge Internal Medicine
VOC-sniffing necklace may support early detection of hypoglycemia
MDedge Internal Medicine
Mortality caused by chronic liver disease in setting of diabetes continues to rise
MDedge Internal Medicine
Metformin linked to lower dementia risk in black patients
MDedge Internal Medicine